// App-Quantinova.ai

1510 : Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries

Researchers

Presenter

  • Gareth Jones

Principal Investigators

  • Brigitte Michelsen

  • Bente Glintborg

  • Bjorn Gudbjornsson

  • Arni Geirsson

  • Heikki Relas

  • Pia Isomäki

  • Jakub Závada

  • Karel Pavelka

  • Ziga Rotar

  • Matija Tomsic

  • Michael Nissen

  • Adrian Ciurea

  • Catalin Codreanu

  • Johan Karlsson Wallman

  • Eirik Kristianslund

  • Simon Rasmussen

  • Lykke Ørnbjerg

  • Maria José Santos

  • Mikkel Østergaard

  • Merete L Hetland

  • Gary Macfarlane

Medical Centers

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

  • Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, Oslo, Norway

  • Rigshospitalet, Glostrup, Denmark

  • Center for Rheumatology Research - University Hospi- tal, Reykjavik, Iceland

  • Department of Endocrinology, Landspitali University Hospital, Reykjavik, Iceland

  • Medical Imaging Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

  • Centre for Rheumatology, Tampere University Hospital, Tampere, Finland

  • Institute of Rheumatology, Prague, Czech Republic

  • Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic

  • University Medical Centre Ljubljana, Ljubljana, Slovenia

  • Hopitaux Universitaires de Geneve, Geneva, Switzerland

  • University Hospital of Zurich, Zurich, Switzerland

  • Center of Rheumatic Diseases, Rheumatology, Bucharest, Romania

  • Lund University, Skne University Hospital, Malmoe, Skne, Sweden

  • Diakonhjemmet Hospital, Division of Rheumatology and Research, Norway, Norway

  • DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark

  • Copenhagen Center for Arthritis Research, Glostrup, Denmark

  • Hospital Garcia de Orta, Almada, Charneca da Caparica, Portugal

  • Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  • Rigshospitalet, Glostrup, Denmark

Locations

  • Brazil

  • United Kingdom

  • Norway

  • Denmark

  • Iceland

  • Finland

  • Czech Republic

  • Slovenia

  • Switzerland

  • Romania

  • Sweden

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Tuberculosis

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved